Tag:
BiolineRx
Latest Headlines
Latest Headlines
BioLineRx shares pop on hep C pact, raising temps in an overheated field
In yet another sign that hepatitis C is becoming one of the most overheated fields in drug development, Israel's BioLineRx ($BLRX) saw its shares shoot up after it struck an early-stage licensing
Ikaria inks $285M pact for heart attack therapy
Israel's BiolineRx has licensed its early-stage BL-1040 heart attack therapy to Ikaria for $285 million in upfront fees and milestones. But Israel's chief scientist will have to sign off on the pact
